Browse by Poster Presenter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

H
Hache, Sophie

Altasciences
(T1230-06-33) Development and Validation of LC-MS/MS Assay Methods to Determine Ubrogepant and Atogepant in Human Breast Milk
Sophie Hache
Favorite
Hacker, Michael

Heinrich-Heine-University Dusseldorf
(M1130-04-21) Rheological Adaptation of Hydrogels as Novel Preclinical In Vitro Model Substitutes for Human Vitreous Body
Michael Hacker
Favorite
Hackett, Jennifer

University of Kansas
(M1230-02-09) Comparative Transcriptomic Profiling of Drug Metabolizing Enzymes and Drug Transporters in the Rabbit Ocular Sub-tissues
Jennifer Hackett
Favorite
Haddad, Fatma

University of Bradford
(T1130-10-57) Preparation of Nebulised Luteolin-Loaded Nano-formulations as a Potential Management for Pulmonary Atrial Hypertension
Fatma Haddad
Favorite
Hageman, Michael

University of Kansas
(M1530-01-04) Exploring Drug Formulation Expert Perspectives on High-Concentration Subcutaneous Formulation Development: A Survey Analysis of Infrastructure, Stakeholder Preferences, and Perceptions
Michael Hageman
Favorite
(T1030-09-50) Amorphous Solid Dispersions of Spray Dried Celecoxib-SBE7βCD-Polymer Ternary Complexes: Enhancements on Intrinsic Dissolution, Crystallization Prevention, and Stabilizing Effects.
Michael Hageman
Favorite
Hahm, Astra

University of Mississippi
(M1030-10-55) Factory-on-a-Pill – a Digital Pill Concept to Deliver Medicines in Space
Astra Hahm
Favorite
Hahn, Annina

University of Bonn
(T0930-01-04) Impact of Penetration Enhancers on Salbutamol Permeation Across Murine Skin
Annina Hahn
Favorite
Haight, Brian

Leistritz Extrusion
(T1030-11-63) Twin Screw Extrusion Process Design and Die Modeling for Directly Extruded Implants
Brian Haight
Favorite
(T1330-11-64) A Novel Material-Sparing Degradation Kinetics Approach for Feasibility Assessment of Twin-Screw Melt Granulation
Brian Haight
Favorite
Hall, Felicia

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Felicia Hall
Favorite
Hall, Stephen

Eli Lilly and Company
(T1130-02-10) Pharmacokinetic Drug-Drug Interactions of Imlunestrant in Healthy Female Participants of Nonchildbearing Potential
Stephen Hall
Favorite
(W0930-02-10) Evaluation of the Disposition and Absolute Bioavailability of Imlunestrant in Healthy Volunteers
Stephen Hall
Favorite
Halpern, Wendy

Genentech, Inc.
(W1230-02-12) Translational PK/PD and First-in-Human Dose Selection of a Monoclonal Antibody Targeting a Membrane Protein
Wendy Halpern
Favorite
Halquist, Matthew

Virginia Commonwealth University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Matthew Halquist
Favorite
Hamadani, Christine

University of Mississippi
(W1130-03-17) Re-engineering of Lipid Nanoparticles Using Ionic Liquids for Brain Drug Delivery
Christine Hamadani
Favorite
Hamid, Khuriah

Universiti Teknologi MARA
(W1130-03-14) Microarray Patches with Cyclodextrin-Carvedilol Complex for Heart Failure Treatment
Khuriah Hamid
Favorite
Hammell, Dana

University of Maryland
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Dana Hammell
Favorite
Hampl, Vojtech

University of Chemistry and Technology
(T0930-05-28) Nanoscale Catch-and-Release - Development of Redispersing Solid Nanocrystalline Drug Forms
Vojtech Hampl
Favorite
Hancock, Bruno

Aleurites LLC
(T1230-10-58) Evaluation of Mitigation Approaches for Nitrosamine Formation in Binary Blends
Bruno Hancock
Favorite
Han, Daewoo

University of Cincinnati
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Daewoo Han
Favorite
Han, Duanduan

Waters Corporation
(T1430-05-26) Lipid Nanoparticle Impurity Analysis: Leveraging Mass Spectrometry to Monitor Impurities and Aldehyde in Raw Materials and Formulated Drugs in Regulated Environments
Duanduan Han
Favorite
(W1030-10-58) Next-Generation Bio-Inert HPLC System for Enhanced Analysis of Biotherapeutics
Duanduan Han
Favorite
Han, Gavin

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Gavin Han
Favorite
Han, Gyoonhee

Yonsei University
(T1530-06-31) Discovery of Potassium Channel K_v7.4(KCNQ4) Selective Activator for the Treatment of Hearing loss
Gyoonhee Han
Favorite
Han, Hyojin

Korea University
(M1330-11-62) Simultaneous Detection of Camostat/Niclosamide Cocrystal and Its Related Impurities via Analytical Quality by Design
Hyojin Han
Favorite
Han, Jiwon

Seoul National University
(M1230-05-30) Exploration of the Utility of Bentonite for Developing a Pediatric Formulation of Everolimus
Jiwon Han
Favorite
(T1130-02-09) Pharmacokinetic Characteristics of Radotinib Assessed in Asian Patients with Chronic Myeloid Leukemia
Jiwon Han
Favorite
Hanna, Michael

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Michael Hanna
Favorite
Hanrahan, Michael

Kansas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
Michael Hanrahan
Favorite
(T1530-11-63) Development of the USP Chapter < 1762 > for Solid-State Nuclear Magnetic Resonance Spectroscopy
Michael Hanrahan
Favorite
(W1230-07-41) Novel Inter-Polymer Complexes in the Development of Spray-Dried Dispersions: A Computational and Experimental Study
Michael Hanrahan
Favorite
Han, Sang-Duk

Dong-A Pharmaceutical Co., Ltd.
(M1330-07-40) Development of Caffeine Customized-Release Tablets Using 3D Printing System and IVIVC Prediction
Sang-Duk Han
Favorite
Hanson, Joshua

Eli Lilly and Company
(T1430-11-64) Reducing Cycle Time While Maintaining Acceptable Granule and Tablet Properties for a Semi-Continuous Fluidized Bed Granulation Process
Joshua Hanson
Favorite
(T1530-11-65) Developing a Spray Flux Equation for a Semi-Continuous Fluid Bed Granulation System
Joshua Hanson
Favorite
Han, SungKyun

Chong Kun Dang Pharmaceutical Corp.
(T1130-07-39) Development of Novel Combination Therapy containing Lobeglitazone and Its Clinical Studies in Patients with Poorly Controlled Type 2 Diabetes
SungKyun Han
Favorite
Hao, Xiaoyu

University of Nebraska Medical Center
(M1230-06-36) A New Neurolysin Activator Ameliorates Brain Injury in Ischemic Stroke Mice
Xiaoyu Hao
Favorite
Haque, Safiya

University of Alabama at Birmingham
(M1030-05-28) In Vitro and In Vivo Evaluation of Topical 4-phenylbutyric Acid Microsponge Formulation as a Potential Antidote Against Arsenical-Induced Skin Injury
Safiya Haque
Favorite
Hardcastle, Chris

Aliri Bioanalysis
(M1130-06-31) Phenyl SPE: A Promising Alternative to More Common Oligonucleotide Extraction
Chris Hardcastle
Favorite
Hardwick, Rhiannon

Bristol-Myers Squibb Company
(W0930-10-56) Leveraging Cross-Species Pharmacokinetic/Pharmacodynamic (PK/PD) Modeling to Drive Discovery Efforts of a Novel Protein Degrader
Rhiannon Hardwick
Favorite
Harkins, Seth

Meso Scale Discovery
(W1230-02-08) Multiplexed Assays for Detection of IgG Antibodies against AAV Serotypes
Seth Harkins
Favorite
Harrell, Charles

Merck & Co., Inc.
(M1430-06-32) Development of Sensitive Method for Antisense Oligonucleotide Therapeutics Using SIMOA Technology
Charles Harrell
Favorite
Harrington, Brent

Pfizer Inc.
(W1230-07-40) Expanding the Design Space of Swellable Core Technology (SCT) for Delivery of Higher Doses and Patient Centric Dosage Form
Brent Harrington
Favorite
Harris, Denise

Alcami Corp
(T1130-10-58) Effective Product Life-Cycle Management Through Continued Process Verification (Stage 3) Using Statistical Software
Denise Harris
Favorite
Harris, Gerald

ICON Plc
(M1430-06-33) The Impact of Unique Stable Label Peptide Internal Standards toward Large Molecule Applications for LC-MS/MS
Gerald Harris
Favorite
Harris, Jeremy

Secant Group
(M1130-09-49) Controlled Release of Proteins with Hydralese^® Formulations for Long-Acting Implants
Jeremy Harris
Favorite
(T1530-07-41) A Tunable, Biodegradable Drug Delivery Platform with Hydralese^TM for Long-Acting Implants
Jeremy Harris
Favorite
Hartig, Michael Uwe

University of Bonn
(W1130-07-39) Investigating ISFIs with PLGA as Sustained Release Formulations for the Urinary Bladder
Michael Uwe Hartig
Favorite
Hartle, Matthew

Aliri Bioanalysis
(W0930-06-34) Validation of an LCMS Hybrid Assay with EVOSEP Cleanup for the Quantitation of Islet Amyloid Polypeptide in Human Plasma
Matthew Hartle
Favorite
Harvey, Ian

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Ian Harvey
Favorite
Harvie, Pierrot

Cytiva
(M1330-07-39) Optimized Prime: A Transformative LNP Composition for Scalable RNA Vaccines
Pierrot Harvie
Favorite
Harville, Tiffany

PPD Laboratories
(M1130-06-34) Comparison of Platform Sensitivities: Correlation of Endogenous Neurofilament-Light Chain Concentration Determination in Human Serum and K₂EDTA Plasma across Immunoassay Platforms
Tiffany Harville
Favorite
Hasabnis, Aakash

University of Minnesota
(W0930-05-30) Broad Applicability of a Model for Predicting Tabletability of Mixtures from Those of Individual Components
Aakash Hasabnis
Favorite
Hasan, Izhar

RH Nanopharmaceuticals
(T1030-07-41) Development of N-Salsalate Parenteral Nanosuspension: A Safe and Effective Analgesic for Post-Operative Pain Management
Izhar Hasan
Favorite
Hasan, Md Mahedi

University of Utah
(M1330-04-19) Stromal Fibrin Inhibition Shapes Immune Infiltration Landscape of Pancreatic Ductal Adenocarcinoma
Md Mahedi Hasan
Favorite
(M1530-04-19) Bioengineering Models to Study Cell-Specific Durotaxis in Pulmonary Arterial Hypertension
Md Mahedi Hasan
Favorite
(T0930-04-24) Identifying the Role of Prion-Like Protein Doppel as a Novel Mediator of Pulmonary Arterial Hypertension
Md Mahedi Hasan
Favorite
Hasan, Md Mahmudul

Moderna, Inc.
(M0930-02-10) Multiplexed Cytokine Measurements in Culture Supernatants upon Ex Vivo Stimulation of Human PBMCs to Assess Cellular Immune Response in Vaccine Studies
Md Mahmudul Hasan
Favorite
(T1530-02-08) Development and Fit-for-Purpose(FFP) Validation of a 35-Color Ex Vivo Stimulation and Activation-Induced Marker (AIM) Assay to Assess Vaccine-Induced Immune Responses in Human Vaccine Trials
Md Mahmudul Hasan
Favorite
Hasan, Md. Nahid

Duquesne University
(T1230-11-61) Reaching an Optimum Calibration-Free Solution: The Role of Numerical Solver Parameters on IOT Prediction of Active Ingredients in Pharmaceutical Powder Blends
Md. Nahid Hasan
Favorite
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Md. Nahid Hasan
Favorite
Hasan, Raquib

Takeda Pharmaceutical Company Limited
(W1230-07-39) Lipid Nanoparticles Particle Size Control: Effect of Buffer and Linear vs Circular mRNA
Raquib Hasan
Favorite
Hasan, Raquibul

Mercer University
(M1030-04-24) Old Dog Learning a New Trick: Statins as Novel Inhibitors of Vascular PDE1A for Regulating Vasodilation and Blood Pressure
Raquibul Hasan
Favorite
Hase, Takeshi

Tokyo Medical and Dental University
(W1030-02-10) Development of a Predictive Model for Vancomycin-Associated Nephrotoxicity Using the Area under the Concentration-Time Curve of Vancomycin: A Machine Learning Analysis
Takeshi Hase
Favorite
Hassiba, Maryam

Qatar University
(M0930-04-20) An Innovative Dual Action Antibiotic Adjuvant Strategy Using Ionic Liquid toward Synergistic Restoration of Activity in MDRO and Enhancing Antimicrobial Activity Against MRSA
Maryam Hassiba
Favorite
Hatsis, Panos

Nido Biosciences, Inc.
(T1030-02-11) Toxicokinetics of NIDO-361, a Potential Candidate to Treat Spinal and Bulbar Muscular Atrophy (SBMA), in Rats and Monkeys Following Oral Dosing in a 13-or 26-Week Toxicity Study
Panos Hatsis
Favorite
Haulenbeek, Jonathan

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Jonathan Haulenbeek
Favorite
Hauther, Christine

Labcorp Biopharma Laboratory Services (BLS)
(W0930-06-33) Receptor Occupancy Assay Development Challenges for Rare Targets of Bispecific Drugs
Christine Hauther
Favorite
Havenith, Vanessa

SE Tylose GmbH & Co. KG
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Vanessa Havenith
Favorite
Haverick, Mark

Merck Sharp & Dohme Corp.
(T1430-06-32) High Throughput N-glycan Analysis of Heavily Glycosylated Protein Therapeutics to Support Real-Time %sialylation Monitoring for Upstream Bioreactors
Mark Haverick
Favorite
Hayashi, Yuji

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Yuji Hayashi
Favorite
Hayata, Nozomi

Eisai Co. Ltd.
(M0930-10-57) Open Label, Single Center, 2 Part Parallel Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties of [¹⁴C]E7386 in Healthy Male Subjects
Nozomi Hayata
Favorite
Hays, Amanda

BioAgilytix
(T0930-06-34) Assessing Parallelism of IFN-beta and IL-29 in Human K2EDTA Plasma Post Stimulation with LPS and PHA
Amanda Hays
Favorite
Heacock, Nathan

GlaxoSmithKline plc
(W1130-11-62) Evaluation of Ice Nucleation/Freezing Phenomenon for a Monoclonal Antibody Drug Product Solution in Primary Container Closure Systems Using a Thermal Cycling Chamber
Nathan Heacock
Favorite
Hearn, Aaron

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Aaron Hearn
Favorite
Hearn, Arkeen

Lonza
(M1030-07-39) Comparative Analysis of Co-Processed AVICEL DG® vs Individual Microcrystalline Cellulose and Anhydrous Dicalcium Phosphate in Tablet Formulation
Arkeen Hearn
Favorite
He, Brian

Bristol-Myers Squibb Company
(T1430-10-56) High-Throughput Analytical: Development of New High-Throughput Experimentation and Analytics Capabilities
Brian He
Favorite
(W1130-10-54) Streamlining Pharmaceutical Process Development: A User-Centric Approach to High-Throughput Analysis
Brian He
Favorite
Hedaya, Mohsen

Kuwait University
(T1230-04-22) Investigation of the Anticonvulsant Effect of a New Oxazolidinone Derivative PH166 in Rats
Mohsen Hedaya
Favorite
Heikkinen, Aki

Certara Predictive Technologies
(M1430-07-40) Mechanistic PBPK Modelling of Itraconazole Oral Solutions: Evaluating HP-β-CD Impact on Solubility and Drug-Drug Interactions
Aki Heikkinen
Favorite
Heinrich, Emmanuel

Hovione PharmaScience SA
(M1230-02-07) Dispersome® as an Advanced Platform for Oral Bioenhancement
Emmanuel Heinrich
Favorite
Heinrich, John

Kanas Analytical Services, LLC
(M1530-11-63) Safe and Effective Analysis of High Potency Compounds Using Solid-State NMR Spectroscopy
John Heinrich
Favorite
Heise, Rebecca

Virginia Commonwealth University
(M1130-07-37) Inflammatory Response to Lipopolysaccharide-Induced Injury and Treatment with Extracellular Matrix-Derived Nanoparticles
Rebecca Heise
Favorite
Heiser, Patrick

Ferring Pharmaceuticals A/S
(M1030-02-11) Demonstration of Virtual Bioequivalence (VBE) Between Progesterone Vaginal Rings Using Mechanistic Vaginal Absorption and Metabolism Model (MechVAM) Within Simcyp Simulator
Patrick Heiser
Favorite
(W1130-02-07) Development and Verification of a Physiologically-Based Pharmacokinetic (PBPK) Model for Vaginal Administration of Progesterone Ring and Gel Formulations
Patrick Heiser
Favorite
Hejmady, Siddhanth

University of Iowa
(W1230-11-64) A Comparative Study of Agitation-Induced Aggregation of Monoclonal Antibodies via Horizontal Shaking and Orbital Shaking
Siddhanth Hejmady
Favorite
He, Lei

Chinese University of Hong Kong, The
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Lei He
Favorite
Henner-Kulkarni, Véronique

SE Tylose GmbH & Co. KG
(M0930-09-50) Predicting Filaments Behavior in Milling and Printing via 3 Point Bend Test
Véronique Henner-Kulkarni
Favorite
(T1330-10-54) Continuous Manufacturing: Rheological Powder Characterisation of Excipients to Understand Their Behaving during the Feeding Step
Véronique Henner-Kulkarni
Favorite
Henner-Kulkarni, Veronique

SE Tylose GmbH (Shin-Etsu)
(M0930-09-50) Predicting Filaments Behavior in Milling and Printing via 3 Point Bend Test
Veronique Henner-Kulkarni
Favorite
Henry, Connor

Aprecia Pharmaceuticals Company
(M0930-07-40) Application of Binder Jetting to Develop 3D Printed Modified Release Tablets
Connor Henry
Favorite
Henson, Samuel

Duquesne University
(W0930-11-65) Transfer of a Low Dose Formulation from Batch to Continuous Manufacturing: High-Shear Wet Granulation to Continuous Twin-Screw Wet Granulation
Samuel Henson
Favorite
He, Qianying

University of Arizona
(M1130-04-24) Excitatory Amino Acid Transporter 2 (EAAT2): A Novel Therapeutic Target for Treatment of Alzheimer’s Disease (AD)
Qianying He
Favorite
Herbert, Aidan

DigiM Solution LLC
(T1230-11-60) Characterizing the Effect of Critical Processing Parameters on Critical Quality Attributes of Protein-Loaded Double Emulsion Microparticles
Aidan Herbert
Favorite
Hernandez-Aceves, Zaira Aydee

Universidad Autónoma del Estado de Morelos
(T1230-03-16) Development and Evaluation of a Drug Delivery System Based on Polymeric Nanoparticles of Nitazoxanide
Zaira Aydee Hernandez-Aceves
Favorite
Herold, Nick

SCIEX
(T1530-10-54) High-Speed Compound Quality Assessment Using Acoustic Ejection Mass Spectrometry
Nick Herold
Favorite
Herr, Alicia

Veralox Therapeutics, Inc.
(W0930-02-11) VLX-1005 Multiple Ascending Dose Pharmacokinetics
Alicia Herr
Favorite
Hervas, Manuel

Patheon, part of Thermo Fisher Scientific
(M1230-07-40) Optimization of Excipients Attributes of Immediate Release Tablet Formulation Using Quality by Design
Manuel Hervas
Favorite
He, Shan

University of Illinois Chicago
(M1330-07-37) Immunoactive Nanoparticle Boosted cDC1 for In Situ Cancer Immunotherapy
Shan He
Favorite
Heshmati, Niloofar

Ashland Specialty Ingredients
(T1530-03-14) Importance of β Cyclodextrin Substitution Level and Type for Solubilization and Stabilization of Poorly Soluble APIs in Parenteral Dosage Forms
Niloofar Heshmati
Favorite
(W1130-03-13) Powerful Tools for Precise Engineering of Viatel^TM Diblock Nanoparticle Size: Polymer and Solvent Structure
Niloofar Heshmati
Favorite
Hess, Samantha

Alexion
(T1030-01-05) Development of Modality-Agnostic Strategies for High Concentration Biologic Candidate Selection
Samantha Hess
Favorite
Hettiarachchi, Suraj

GlaxoSmithKline plc
(M1130-10-58) Mechanistic Investigation of Gamma Irradiation Effects on Physicochemical Stability of Excipients Used in Colloidal Injectable Suspensions
Suraj Hettiarachchi
Favorite
He, Yanying

Purdue University
(W0930-07-37) Nanoparticle Development for Systemic Delivery of Resiquimod to Reactivate Immunosuppressive Tumor Microenvironment
Yanying He
Favorite
He, Yixin

Aptacure Therapeutics Ltd
(T0930-06-36) Development of a Novel LC-MS/MS Method for Quantitation of a Therapeutic Aptamer in Rat Plasma
Yixin He
Favorite
Heyns, Ingrid

University of Alabama
(T1130-01-03) Urolithin-A Laden Nanoparticles Upregulate Heme Oxygenase (HO-1) and Enhance Mitochondrial Quality Control in Mouse Model of Cisplatin-Induced Acute Kidney Injury
Ingrid Heyns
Favorite
(T1130-01-04) Comprehensive Strategy for Type 2 Diabetes: Non-competitive Ligand-Based Oral Delivery of Curcumin Combined with Long-Acting Insulin to Prevent Secondary Complications
Ingrid Heyns
Favorite
Hickey, Anthony

RTI International
(M0930-03-16) Optimizing Storage Conditions to Maintain Chemical Stability and Aerodynamic Performance of Tigecycline Inhalation Powder
Anthony Hickey
Favorite
Hiew, Tze Ning

University of Iowa
(M1130-01-01) The Importance of Surface Composition and Wettability on the Dissolution Performance of High Drug Loading Amorphous Dispersion Formulations
Tze Ning Hiew
Favorite
Higashino, Chie

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Chie Higashino
Favorite
Higashino, Haruki

Pharmaron (Exton) Lab Services LLC
(T1030-02-08) The Potential of In Vitro Dissolution Absorption System 2 (IDAS2) as a Bioequivalence Decision Tool
Haruki Higashino
Favorite
Higuchi, Masaharu

Asahi Kasei Corporation
(M1330-10-56) Comparative Study of Suitability for Wet Continuous Manufacturing Process Using MCC with Different Characteristics - Part 2
Masaharu Higuchi
Favorite
Hill, Salisha

Inotiv, Inc.
(T1230-06-31) A Technical Evaluation of Targeted Protein Quantification in Formalin Fixed Paraffin Embedded Tumor Sections by Mass Spectrometry Including Antibody Drug Conjugates (ADC)
Salisha Hill
Favorite
Hindle, Michael

Virginia Commonwealth University
(W1030-01-04) In Vitro Characterization and In Vivo Efficacy Study of a 2nd Generation Synthetic Lung Surfactant (SLS) Excipient Enhanced Growth (EEG) Dry Powder Formulation and Device
Michael Hindle
Favorite
Hinterberg, Michael

SomaLogic
(M0930-10-54) Utilization of Proteomic Surrogates for Early Detection of Unexpected Drug Benefits
Michael Hinterberg
Favorite
Hirabayashi, Manabu

Chugai Research Institute for Medical Science Inc.
(T1130-02-07) Novel Method of Quantitatively Predicting the Clearance of Uridine Diphosphate-Glucuronosyltransferase Substrates Using Human Liver Chimeric Mice
Manabu Hirabayashi
Favorite
Hiranita, Takato

University of Texas Health Science Center
(T1130-06-36) Synthesis and Biological Evaluation of Dual Acting Sigma Receptor Ligands and Dopamine Transporter Ligands as Potential Treatment Cocaine Misuse
Takato Hiranita
Favorite
Hirschman, Jordan

Bristol-Myers Squibb Company
(W1130-07-37) Drug Product Development Approaches to Overcome Stability Challenges of Antibody Drug Conjugates (ADCs)
Jordan Hirschman
Favorite
Hivin, Elisa

Aliri Bioanalysis
(M0930-06-32) Development of Quantitative MALDI Mass Spectrometry Imaging Methods for Studying Distribution of Antituberculosis Drugs at Their Site of Action
Elisa Hivin
Favorite
(W1030-02-08) Distribution of Standard-of-Care Antituberculosis Drugs in Cynomolgus Macaque Lungs
Elisa Hivin
Favorite
Hoag, Stephen

University of Maryland
(M1430-03-18) Optimizing Semi-Solid Extrusion 3D Printed Hydrochlorothiazide Tablets: The Role of Rheological Properties and Drying Methods on Structure and Appearance
Stephen Hoag
Favorite
(T1030-05-25) Enhancing Lyoprotectant Diversity via High-throughput Screening to the Boost Post-lyophilization Viability of Live Biotherapeutics
Stephen Hoag
Favorite
(T1130-05-29) Sodium Alginate-Based Bio-Adhesive Hydrogel: A Hemostatic Agent, Endoscopically Deliverable to the Gastrointestinal Resection Site
Stephen Hoag
Favorite
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Stephen Hoag
Favorite
(T1330-11-61) NIR-Based Quality Analytics for Semisolid Extrusion 3D Drug Printing
Stephen Hoag
Favorite
(T1430-11-62) What Is That Peak in Hydrocodone Bitartrate USP Reference Standard?
Stephen Hoag
Favorite
(W0930-05-28) Enhancing Oral Delivery of Alginate-Encapsulated Probiotics: The Novel and Versatile Role of Casein as an Excipient
Stephen Hoag
Favorite
(W1230-09-48) Understanding the Influence of Occlusion on Oxybutynin Permeation from a Transdermal Gel Deposited Film Using IVPT
Stephen Hoag
Favorite
Hochart, Guillaume

Aliri Bioanalysis
(T1330-01-05) Exploring the Spatial Distribution of mRNA-Lipid Nanoparticles in Mouse Whole-Body and Isolated Organs Using MALDI MSI
Guillaume Hochart
Favorite
Hofasaess, Martin

BASF Corporation
(T1530-09-52) Leveraging an Algorithm-Based Digital Platform for Excipient selection facilitating Formulation Development of Poorly Soluble Active Pharmaceutical Ingredients
Martin Hofasaess
Favorite
Ho, Gloria

BASF Corporation
(W1130-10-57) Assessing Topical Dosage Form Manufacturing Methods and Their Impact on Globule Microstructure with Non-Invasive Micro-CT Analysis
Gloria Ho
Favorite
(W1230-10-55) In Vivo Evaluation of Cocoyl Caprylocaprate on API Skin Permeation and Bioavailability
Gloria Ho
Favorite
Holgate, Rob

Abzena
(M1530-06-36) Platform Approach for Identifying the Most Functional and Developable Bispecific T Cell Engager
Rob Holgate
Favorite
(W1230-02-07) EpiScreen®2.0 Time Course Assay: A Sensitive and Data Rich Tool for Pre-Clinical Immunogenicity Testing of Biologics
Rob Holgate
Favorite
Holkunde, Aditi

University of Mississippi
(T1030-01-04) Formulation Development and Characterization of Isoniazid-Pyridoxine Combination Gummies Using an Extrusion-Based 3D Printer
Aditi Holkunde
Favorite
Hollenbeck, Gary

University of Maryland Baltimore
(T1230-01-06) A Novel Approach Using an Organic Phase Nanosuspension to Enhance Drug Loading of Hydrophilic Compounds in Nanoparticles
Gary Hollenbeck
Favorite
Hollmann, Travis

Bristol-Myers Squibb Company
(T0930-06-31) Non-Tissue Based Screening Methods for Selection of Immunohistochemistry Antibody Candidates
Travis Hollmann
Favorite
Holstein, Sarah

University of Nebraska Medical Center
(T1330-04-22) Exploring the Synergistic Potential of Fatty Acid Synthase Inhibitors and Geranylgeranyl Diphosphate Synthase Inhibitors in Myeloma Therapy
Sarah Holstein
Favorite
Hong, Paula

Waters Corporation
(T1030-11-62) Impacts of Method Conditions and Autosampler Characteristics on Method Migration
Paula Hong
Favorite
Hong, Shiqi

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Shiqi Hong
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Shiqi Hong
Favorite
Hopkins, Corey R.

University of Nebraska Medical Center
(M1230-04-23) Design, Synthesis, and Evaluation of Claudin-1 Inhibitors for the Treatment of Metastatic Colorectal Cancer
Corey R. Hopkins
Favorite
Hopkins, Phillip

Merck & Co., Inc.
(T1130-02-08) In Vitro Selectivity of Several Bile Acid Glucuronides as OATP1B Endogenous Biomarkers
Phillip Hopkins
Favorite
Hoque, Md. Tozammel

University of Toronto
(M1530-04-22) Anti-Viral and Anti-Inflammatory Effects of Novel PPARγ Agonist, INT131, in an EcoHIV Mouse Model: Relevance to the Treatment of HIV-Associated Neurocognitive Disorders
Md. Tozammel Hoque
Favorite
Hornick, Timothy

DigiM Solution LLC
(M1530-09-52) Mass Transport Modeling and In Silico Formulation of Osmotic Controlled Release Tablets with Microscopy-Based Digital Twins
Timothy Hornick
Favorite
Ho, Rodney

University of Washington
(W1230-10-58) A Stable and Scalable Gemcitabine and Paclitaxel Drug Combination Nanoparticle (DcNP) Exhibits Long-Acting Pharmacokinetics and Breast Tumor Regression in an Orthotopic 4T1 Mouse Model
Rodney Ho
Favorite
Horvath, Robert

University of Cincinnati
(M0930-05-27) Non-woven Polymeric Fiber Mats for Female-Initiated On-Demand Contraception Without Hormones
Robert Horvath
Favorite
Hoshino, Takafumi

Shin-Etsu Chemical Co., Ltd.
(T1030-09-51) Simplification Study of Feed System in HPMCAS Dry Coating
Takafumi Hoshino
Favorite
Hossain, Jasmin

Long Island University
(T0930-02-12) A PBPK Model to Simulate Intranasal Naloxone Rescue from Fentanyl Overdose
Jasmin Hossain
Favorite
Hossain, Md Nayeem

US Food and Drug Administration
(W1230-07-38) Ethanol Solubility of Rate Controlling Polymer in Modified Release Formulation Can Impact Alcohol Dose Dumping: An Assessment Through Principal Component Analysis
Md Nayeem Hossain
Favorite
Ho, Tien

Gilead Sciences, Inc.
(T1530-10-56) Development of In Vitro/In Vivo Correlation for Long-Acting Suspensions via Bootstrapping
Tien Ho
Favorite
Hough, Loren

University of Colorado Boulder
(T1230-06-32) Plasmon-Waveguide Resonance Spectroscopy to Evaluate Mucin and Phage-like Particle (PLP) Interactions
Loren Hough
Favorite
Hou, Shuyu

Medpace
(T1030-06-36) Liquid Chromatography – Tandem Mass Spectrometry for Quantification of Zymostenol and Lathosterol in Human Serum with High Specificity and Low Background Noise
Shuyu Hou
Favorite
(W1030-02-07) Determination of the Concentration of Monoclonal Antibodies (Mab) Drug in Human Serum Using an Enzyme-Linked Immunosorbent Assay (ELISA)
Shuyu Hou
Favorite
Howlader, Md Sariful Islam

Texas Tech University Health Science Center
(W0930-04-20) Kruppel-Like Factor 2 (KLF2) Reduces Parameters of Coronavirus Disease-Related Pathogenesis
Md Sariful Islam Howlader
Favorite
Ho, Yenyi

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Yenyi Ho
Favorite
Ho, Yunn-Fang

National Taiwan University
(T1430-02-08) Ontogeny of Drug Metabolizing Enzymes and Its Impact on Valproic Acid Hepatotoxicity: Insights from In Vitro and PBPK Modeling Studies
Yunn-Fang Ho
Favorite
Ho, Ziyu

Virginia Polytechnic Institute and State University
(W1130-11-64) Reverse Engineering of the Sublocade^® Buprenorphine In Situ Forming Implant
Ziyu Ho
Favorite
Hsuan Su, Tien

Midwestern University
(T1430-09-50) Amelioration of Drug-Induced Nephrotoxicity Using Ganglioside Liposomes
Tien Hsuan Su
Favorite
Huang, Chunghui

Auburn University
(M0930-05-28) Disulfiram-Loaded Metal-Organic Nanoparticles Trigger Immunogenic Cell Death of the Triple-Negative Breast Cancer
Chunghui Huang
Favorite
Huang, Cong

ICE Bioscience
(T1030-04-21) A PARPi Screening Cascade to Facilitate Novel Drug Discovery
Cong Huang
Favorite
Huang, Haibin

Yurogen Biosystems (an ABclonal Company)
(M1530-04-21) From Sequence to Binding Clones, a Novel Computational Platform for Nanobody Discovery
Haibin Huang
Favorite
Huang, Hui Yu

Meiji Biopharmaceutical Corporation (Guangzhou) Limited
(M1030-09-50) Rediscovery of Paclitaxel: A Novel Oral Paclitaxel Softgel Capsule Product for Improving Cancer Therapeutics
Hui Yu Huang
Favorite
Huang, Jiayi

Roquette Asia Pacific Pte. Ltd.
(W1030-07-37) Formulation with Hydroxypropyl ß-Cyclodextrin Preserves the Potency of Adenovirus Vectors Under Heat and Light Stress
Jiayi Huang
Favorite
(W1230-07-37) Hydroxypropyl Beta-Cyclodextrin as a Multifunctional Excipient for Downstream Processing and Formulation of Monoclonal Antibodies
Jiayi Huang
Favorite
Huang, Jing

WuXi AppTec Co., Ltd.
(W0930-06-31) Simultaneous Quantification of Multiple ADC Component Concentrations and DAR Profiling with One Aliquot of Plasma in NHP Toxicology Study by Hybrid LC-MS
Jing Huang
Favorite
Huang, Pin-Syuan

University of Minnesota
(M1130-11-64) Decreased Crystal Plasticity by Solvation-The Case of Levofloxacin Acesulfame
Pin-Syuan Huang
Favorite
Huang, Qiao

Chinese University of Hong Kong, The
(M1230-02-11) Novel Quantification Method for Evaluation of Hair Growth in Mice
Qiao Huang
Favorite
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Qiao Huang
Favorite
Huang, Richard jun

Meiji Biopharmaceutical Corporation(Guangzhou) Limited
(M1030-09-50) Rediscovery of Paclitaxel: A Novel Oral Paclitaxel Softgel Capsule Product for Improving Cancer Therapeutics
Richard jun Huang
Favorite
Huang, Ruea-Yea

State University of New York
(M1230-06-32) Identification of Small Molecule APJ Receptor Antagonists for Treatment of Cancers
Ruea-Yea Huang
Favorite
Huang, Yang

Yurogen Biosystems (an ABclonal Company)
(T1130-04-20) Development of CD40 and HER2 Bispecific Antibodies for Enhanced Efficacy against HER2-Positive Tumors
Yang Huang
Favorite
(W0930-06-35) Development of Rabbit Anti-Mertansine (DM1) Monoclonal Antibodies
Yang Huang
Favorite
Huang, Yicheng

University of Queensland
(M1230-06-34) Influence of Quantitative Differences in Propylene Glycol on the Performance of Diclofenac Sodium Topical Gels
Yicheng Huang
Favorite
Huang, Yongzhuo

Chinese Academy of Sciences
(T1030-01-06) The Influence of Nanostructural Characteristics on Gene Transfection: Enhanced DNA Delivery Through Macropinocytosis and Efficient Dissociation by Large, Botryoid-Shaped Nanoparticles
Yongzhuo Huang
Favorite
(T1230-03-18) Targeting Brain Metastasis in Non-Small Cell Lung Cancer with EGFRT790M Mutation Using BBB-Penetrating Codelivery Liposomes
Yongzhuo Huang
Favorite
Huang, Yu

City University of Hong Kong
(T1530-02-12) Druggability Evaluation of ZEX, a Novel Derivative of Component from Codonopsis Radix
Yu Huang
Favorite
Huang, Yu-Ting

National Taiwan University
(T1430-02-08) Ontogeny of Drug Metabolizing Enzymes and Its Impact on Valproic Acid Hepatotoxicity: Insights from In Vitro and PBPK Modeling Studies
Yu-Ting Huang
Favorite
Hubbard, Oliver

University of Utah
(M1330-03-13) Artificial Extracorporeal Replicate for Drugs (AER_x): A Low-Cost Extracorporeal Membrane Oxygenator (ECMO) Mimic for High Throughput Drug Screening
Oliver Hubbard
Favorite
Hu, Bohan

InnoGI Technologies
(W1130-07-40) Integrating Bioaccessibility Data from the Tiny-TIMsg into a Physiologically Based Biopharmaceutics Model (PBBM) of a BCS Class IV Compound to Predict Pharmacokinetic (PK) Performance
Bohan Hu
Favorite
Hu, Dan

WuXi AppTec Co., Ltd.
(T1330-06-31) Method Development and Validation of a Cell-Based Assay for the Detection of Anti-AAV Neutralizing Antibodies in Human Serum
Dan Hu
Favorite
Hu, Jiun-Wen

Andros Pharmaceuticals Co., Ltd.
(M1030-01-02) Development of Tretinoin-loaded Lipid Nanoparticles for Topical Drug Delivery
Jiun-Wen Hu
Favorite
(W1130-03-16) Development of Novel Local Anesthetics-Clay Composite Formulations to Improve Stability and Reduce Onset Time
Jiun-Wen Hu
Favorite
Hu-Lieskovan, Siwen

University of Utah
(T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
Siwen Hu-Lieskovan
Favorite
(T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
Siwen Hu-Lieskovan
Favorite
Huls, Nicholas

Purdue University
(T1430-11-60) Determining Impact of Particle Size and Crystal Quality on Formation of Nitrosamine in API and Drug Formulations
Nicholas Huls
Favorite
(W1230-11-65) Effect of Lyophilization Process Parameters on the Stability of mRNA Lipid Nanoparticles (LNP)
Nicholas Huls
Favorite
Humes, Matt

Beam Therapeutics
(M1130-06-32) A Chilled Liquid Handler Deck Enables the Automation of Lipid LC-MS/MS Bioanalytical Assays
Matt Humes
Favorite
Hu, Ming

University of Houston
(M1130-02-12) A Mechanistic Rat PBPK Model for Genistein and Its Glucuronide Metabolite: Integrating Liver and Enteric Metabolism with Transporter-Mediated Biliary and Enteroluminal Clearance
Ming Hu
Favorite
Hu, Mingxin

BeiGene (Beijing) Ltd., Co.
(T0930-10-54) Evaluation of PBPK Modeling in Predicting the Distribution and PK of Targeted Protein Degraders in Preclinical Species
Mingxin Hu
Favorite
Humphrey, James

Croda Inc.
(W0930-09-48) Impact of Excipient Purity on the Stability of Chemotherapy Drugs
James Humphrey
Favorite
Huncosky, Emily

PPD Laboratories
(M1330-11-60) The Effects of Interfering Viral Particles on the Probability of Detecting Replication-Competent Adeno-Associated Virus (rcAAV) in a Replication-Based Cell Assay
Emily Huncosky
Favorite
Hunt, Hazel

Corcept Therapeutics
(T1330-02-12) A Phase 1, Open-Label, Drug-Drug Interaction Study Designed to Evaluate the Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-gp Substrate Dabigatran Etexilate in Healthy Subjects
Hazel Hunt
Favorite
Huo, Jiaheng

Gilead Sciences, Inc.
(T1430-10-55) Manual 2D LC-MS for Peak Purity Assessment of Atropisomeric Compound
Jiaheng Huo
Favorite
Hurley, Casey

Gilead Sciences, Inc.
(T1430-10-58) Understanding Nitrite Loss in Pharmaceutical Drug Products and its Impact on N‑Nitrosamine Formation
Casey Hurley
Favorite
Hu, Yang

Regeneron Pharmaceuticals, Inc.
(M1430-09-48) Combining Arrhenius Kinetics and Monte Carlo Simulation to Enhance Stability Prediction for Antibodies
Yang Hu
Favorite
Hu, Yanjun

WuXi AppTec Co., Ltd.
(M1030-06-33) The Application of 19F-NMR in the Analysis of Drug-Related Substances of Leritrelvir (RAY1216) in Human Urine and Fecal Samples to Support a Phase I Clinical Study
Yanjun Hu
Favorite
Hwa, Joyce

WuXi AppTec Co., Ltd.
(M1030-04-21) Overexpression of Human ApoC3 in Mice Leads to Hypertriglyceridemia and Induces Key CVD-related Lipid Biomarkers
Joyce Hwa
Favorite
(W0930-02-08) Lumbar Intrathecal Infusion of an siRNA Formulation via Cannulation in Rats Demonstrated Comparable Tissue Distributions and Improved Animal Response as Comparing to Non-Cannulated Free Hand Method
Joyce Hwa
Favorite
Hwang, Jee-Yeon

Creighton University
(T1230-09-53) Development of siRNA Incorporated PEGylated and Polysorbate 80 Coated Polymeric Nanoparticles for Global Cerebral Ischemia
Jee-Yeon Hwang
Favorite
Hwang, Sung Joo

Yonsei University
(M1030-09-48) Polysaccharide Emulsion Gels for Reducing Postoperative Adhesions and Delivering 5-Fluorouracil
Sung Joo Hwang
Favorite
(M1230-10-57) Formulation of an Oil-in-Hydrogel Anti-Adhesion System for Sustained Release of Liposomes-Encapsulated 5-Fluorouracil
Sung Joo Hwang
Favorite
(T0930-07-39) Improving the Solubility of Apixaban and Preparation Sustained-Release Tablets Through a Solidified Self-Microemulsifying Drug Delivery System
Sung Joo Hwang
Favorite
(T1430-09-49) Preparation and Evaluation of 5-Fluorouracil Loaded Oil In Water Emulgel for Anti-Adhesion and Cancer Chemotherapy
Sung Joo Hwang
Favorite
Hyun, Sangmin

Dong-A ST
(M1130-01-02) Preparation and Evaluation of Pramipexole Transdermal Patch: In Vitro and In Vivo Study
Sangmin Hyun
Favorite